AI assistant
Cingulate Inc. — Regulatory Filings 2021
Oct 14, 2021
34936_rns_2021-10-14_649786d2-4a56-42d4-b5aa-2d33a9f7b4c6.zip
Regulatory Filings
Open in viewerOpens in your device viewer
CORRESP 1 filename1.htm
October 14, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: |
|---|
| Registration Statement on Form S-1 |
| File No. 333-259408 |
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on October 12, 2021, in which we, as representative of the several underwriters of Cingulate Inc.’s proposed initial public offering of common stock, joined Cingulate Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for Thursday, October 14, 2021, at 4:30 p.m. Eastern Time. Cingulate Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
OPPENHEIMER & CO. INC.
As representative of the
several Underwriters
| OPPENHEIMER
& CO. INC. | |
| --- | --- |
| By: | /s/
Matthew Dormer |
| Name: | Matthew
Dormer |
| Title: | Managing
Director |
Field: Page; Sequence: 1; Options: Last
Field: /Page